Rachael Lester

Insider Reports History

Location
South San Francisco, CA
Signature
/s/ Christopher Ogden, as Attorney-in-Fact for Rachael Lester
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Rachael Lester:

Company Role Class Num Shares Value Price $ Report Date Ownership
CytomX Therapeutics, Inc. Chief Business Officer Common Stock 20,000 $85,200 $4.26 02 Feb 2026 Direct
CytomX Therapeutics, Inc. Chief Business Officer Performance Stock Units (PSUs) 50,000 02 Feb 2026 Direct
CytomX Therapeutics, Inc. Chief Business Officer Stock Option (Right to Buy) 50,000 02 Feb 2026 Direct

Insider Reports Filed by Rachael Lester

Symbol Company Period Transactions Value $ Form Type Role Filing Time
CTMX CytomX Therapeutics, Inc. 02 Feb 2026 3 $0 4 Chief Business Officer 04 Feb 2026, 16:28
CTMX CytomX Therapeutics, Inc. 20 Oct 2025 1 $0 4 Chief Business Officer 29 Oct 2025, 16:50
CTMX CytomX Therapeutics, Inc. 20 Oct 2025 0 $0 3 Chief Business Officer 29 Oct 2025, 16:49